Insights from The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study on The Use of Intensive Glycemic Treatment to Reduce The Risk of Complications of Type 1 Diabetes
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Endocrine Practice
- Vol. 12, 34-41
- https://doi.org/10.4158/ep.12.s1.34
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Sustained Effect of Intensive Treatment of Type 1 Diabetes Mellitus on Development and Progression of Diabetic NephropathyJAMA, 2003
- Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes MellitusNew England Journal of Medicine, 2003
- Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial.Diabetes, 1999
- The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications TrialDiabetes, 1995
- Progression of Retinopathy with Intensive versus Conventional Treatment in the Diabetes Control and Complications TrialOphthalmology, 1995
- Implementation of Treatment Protocols in the Diabetes Control and Complications TrialDiabetes Care, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993